Pacira BioSciences Inc.

NASDAQ: PCRX · Real-Time Price · USD
24.96
-0.03 (-0.12%)
At close: Aug 15, 2025, 12:11 PM

Pacira BioSciences Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
276.77M 153.3M 104.14M 585.58M
Short-Term Investments
207.84M 125.28M 184.51M 70.83M
Long-Term Investments
n/a 2.41M 64.38M 21.99M
Other Long-Term Assets
35.65M 36.05M n/a n/a
Receivables
113.3M 105.56M 98.4M 96.32M
Inventory
125.28M 104.35M 96.06M 98.55M
Other Current Assets
21.93M 21.5M 15.22M 14.77M
Total Current Assets
745.13M 509.99M 498.33M 866.05M
Property-Plant & Equipment
216.39M 234.95M 254.39M 264.81M
Goodwill & Intangibles
425.97M 646.5M 703.79M 769.14M
Total Long-Term Assets
808.39M 1.06B 1.18B 1.21B
Total Assets
1.55B 1.57B 1.68B 2.08B
Account Payables
19.13M 15.7M 15.22M 10.54M
Deferred Revenue
n/a n/a n/a 10.13M
Short-Term Debt
201.78M 8.64M 42.77M 374.7M
Other Current Liabilities
28.81M 42.56M 54.47M 9.38M
Total Current Liabilities
309.92M 97.38M 147.77M 521.12M
Long-Term Debt
383.55M 513.8M 655.82M 674.53M
Other Long-Term Liabilities
37.06M 38.27M 37.79M 67.44M
Total Long-Term Liabilities
465.25M 606.87M 758.42M 823.83M
Total Liabilities
775.17M 704.26M 906.19M 1.34B
Total Debt
638.85M 586.04M 763.39M 1.13B
Common Stock
47K 46K 46K 45K
Retained Earnings
-206.36M -106.8M -148.75M -211.9M
Comprehensive Income
343K 247K -380K 167K
Shareholders Equity
778.35M 870.13M 775.01M 730.41M
Total Investments
207.84M 127.69M 248.89M 92.82M